However, LRRK2 kinase activation may have much broader application as an underlying disease mechanism; for example, in carriers of additional LRRK2 variants of unknown clinical significance3, in idiopathic PD4 and carriers of the PD causing VPS35 D620N mutation5. Here, VPS35 is linked to Parkinson disease.